{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:30Z","timestamp":1789039770602,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:00:00Z","timestamp":1622332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:00:00Z","timestamp":1622332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10620-021-07056-5","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T19:21:32Z","timestamp":1622402492000},"page":"2646-2654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"67","author":[{"given":"Jennie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-2806","authenticated-orcid":false,"given":"Robert J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,30]]},"reference":[{"key":"7056_CR1","volume-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global Tuberculosis Report 2019. Geneva: World Health Organization; 2020."},{"key":"7056_CR2","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","volume":"54","author":"A Cohen","year":"2019","unstructured":"Cohen A, Mathiasen VD, Schon T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54:1900655. https:\/\/doi.org\/10.1183\/13993003.00655-2019.","journal-title":"Eur Respir J."},{"key":"7056_CR3","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modeling. PLoS Med. 2016;13:e1002152. https:\/\/doi.org\/10.1371\/journal.pmed.1002152.","journal-title":"PLoS Med."},{"key":"7056_CR4","volume-title":"Global hepatitis report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017."},{"key":"7056_CR5","unstructured":"Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services; 2020."},{"key":"7056_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1164\/rccm.201206-1039ED","volume":"186","author":"RR Reves","year":"2012","unstructured":"Reves RR, Nolan CM. Tuberculosis elimination in the United States: an achievable goal or an illusion? Am J Respir Crit Care Med 2012;186:1\u20133. https:\/\/doi.org\/10.1164\/rccm.201206-1039ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"7056_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6907a1","volume":"69","author":"B Cole","year":"2020","unstructured":"Cole B, Nilsen DM, Will L, Etkind SC, Burgos M, Chorba T. Essential components of a public health tuberculosis prevention, control and elimination Program: recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association. MMWR Recomm Rep. 2020;69:1\u201327.","journal-title":"MMWR Recomm Rep."},{"key":"7056_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/aje\/kwt246","volume":"179","author":"KM Shea","year":"2014","unstructured":"Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR Jr. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014;179:216\u2013225.","journal-title":"Am J Epidemiol."},{"key":"7056_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","volume":"69","author":"TR Sterling","year":"2020","unstructured":"Sterling TR, Njie G, Zenner D et al. Guideline for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020;69:1\u201311.","journal-title":"MMWR Recomm Rep."},{"key":"7056_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269\u20131278.","journal-title":"Lancet Infect Dis."},{"key":"7056_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.30831","volume":"71","author":"MH Le","year":"2020","unstructured":"Le MH, Hyi Yeo Y, Cheung R, Henry L, Lok AS, Nguyen MH. Chronic hepatitis B prevalence among foreign-born and U.S.-born adults in the United States, 1999\u20132016. Hepatology 2020;71:431\u2013443.","journal-title":"Hepatology"},{"key":"7056_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","volume":"115","author":"JK Lim","year":"2020","unstructured":"Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of chronic hepatitis B virus infection in the United States. Am J Gastroenterol. 2020;115:1429\u20131438.","journal-title":"Am J Gastroenterol."},{"key":"7056_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cgh.2019.05.047","volume":"18","author":"K Zhou","year":"2020","unstructured":"Zhou K, Terrault NA. Gaps in viral hepatitis awareness in the United States in a population-based study. Clin Gastroenterol Hepatol. 2020;18:188\u2013195. https:\/\/doi.org\/10.1016\/j.cgh.2019.05.047.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"8","key":"7056_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.37765\/ajmc.2020.44069","volume":"26","author":"AM Harris","year":"2020","unstructured":"Harris AM, Osinubi A, Nelson NP, Thompson WW. The hepatitis B care cascade using administrative claims data, 2016. Am J Manag Care 2020;26:331\u2013338.","journal-title":"Am J Manag Care"},{"key":"7056_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00004836-200204000-00021","volume":"34","author":"RC Cheung","year":"2002","unstructured":"Cheung RC, Hanson AD, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002;34:476\u2013480.","journal-title":"J Clin Gastroenterol."},{"key":"7056_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.1572-0241.2002.05704.x","volume":"97","author":"PA Patel","year":"2002","unstructured":"Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol. 2002;97:1198\u20131203.","journal-title":"Am J Gastroenterol."},{"key":"7056_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008\u20132012.","journal-title":"JAMA"},{"key":"7056_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M et al. Preferred reporting items for systemic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. https:\/\/doi.org\/10.1186\/2046-4053-4-1.","journal-title":"Syst Rev."},{"key":"7056_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1164\/arrd.1986.134.4.666","volume":"134","author":"KA McGlynn","year":"1986","unstructured":"McGlynn KA, Lustbader ED, Sharrar RG, Murphy EC, London WT. Isoniazid prophylaxis in hepatitis B carriers. Am Rev Respir Dis. 1986;134:666\u2013668. https:\/\/doi.org\/10.1164\/arrd.1986.134.4.666.","journal-title":"Am Rev Respir Dis."},{"key":"7056_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/oxfordjournals.aje.a114659","volume":"126","author":"KA McGlynn","year":"1987","unstructured":"McGlynn KA, Lustbader ED, London WT, Heyward WL, McMahon BJ. Hepatitis B virus replication and tuberculin reactivity: studies in Alaska. Am J Epidemiol. 1987;126:38\u201343.","journal-title":"Am J Epidemiol."},{"key":"7056_CR21","unstructured":"Larke RP, Harley DD, Enarson DA. Relationship between tuberculin reactivity and hepatitis B virus infection in the Northwest Territories. Arctic Med Res. 1991;Suppl:371\u2013373"},{"key":"7056_CR22","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cmi.2019.01.021","volume":"25","author":"H Xin","year":"2019","unstructured":"Xin H, Zhang H, Liu J et al. Mycobacterium tuberculosis infection among the elderly in 20 486 rural residents aged 50\u201370 years in Zhongmu County China. Clin Microbiol Infect. 2019;25:1120\u20131126.","journal-title":"Clin Microbiol Infect."},{"key":"7056_CR23","doi-asserted-by":"publisher","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","volume":"10","author":"R Miramontes","year":"2015","unstructured":"Miramontes R, Hill AN, Yelk Woodruff RS et al. Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011\u20132012. PLoS ONE 2015;10:e0140881. https:\/\/doi.org\/10.1371\/journal.pone.0140881.","journal-title":"PLoS ONE"},{"key":"7056_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5009\/gnl.2013.7.4.450","volume":"7","author":"D Chu","year":"2013","unstructured":"Chu D, Yang JD, Lok AS et al. Hepatitis B screening and vaccination practices in asian american primary care. Gut Liver 2013;7:450\u2013457.","journal-title":"Gut Liver"},{"key":"7056_CR25","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1007\/s10620-010-1439-3","volume":"56","author":"M Khalili","year":"2011","unstructured":"Khalili M, Guy J, Yu A et al. Hepatitis B and hepatocellular carcinoma screening among asian americans: survey of safety net healthcare providers. Dig Dis Sci. 2011;56:1516\u20131523.","journal-title":"Dig Dis Sci."},{"key":"7056_CR26","unstructured":"Keisler-Starkey K, Bunch, L. U.S. Census Bureau current population reports, P60-271, health insurance coverage in the United States: 2019. Washington, DC: U.S. Government Publishing Office, 2020."},{"key":"7056_CR27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2105\/AJPH.2012.300781","volume":"103","author":"JP Cegielski","year":"2013","unstructured":"Cegielski JP, Griffith DE, McGaha PK et al. Eliminating tuberculosis one neighborhood at a time. Am J Public Health 2013;103:1292\u20131300.","journal-title":"Am J Public Health"},{"key":"7056_CR28","doi-asserted-by":"crossref","unstructured":"Harris AM, Link-Gelles R, Kim K, et al. Community-based services to improve testing and linkage to care among non-U.S.-born persons with chronic hepatitis B virus infection\u2014three U.S. programs, October 2014\u2013September 2017. MMWR Morb Mortal Wkly Rep. 2018;67:541\u2013546.","DOI":"10.15585\/mmwr.mm6719a2"},{"key":"7056_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12889-015-1600-1","volume":"15","author":"SE Demlow","year":"2015","unstructured":"Demlow SE, Oh P, Barry PM. Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010\u20132012. BMC Public Health 2015;15:263. https:\/\/doi.org\/10.1186\/s12889-015-1600-1.","journal-title":"BMC Public Health"},{"key":"7056_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/hep.30246","volume":"69","author":"MH Nguyen","year":"2019","unstructured":"Nguyen MH, Lim JK, Burak Ozbay A et al. Advancing age and comorbidity in a US insured population-based cohort of patients with chronic hepatitis B. Hepatology 2019;69:959\u2013973.","journal-title":"Hepatology"},{"key":"7056_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41424-018-0007-6","volume":"9","author":"A Liu","year":"2018","unstructured":"Liu A, Le A, Zhang J et al. Increasing comorbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000\u20132015. Clin Transl Gastroenterol. 2018;9:141. https:\/\/doi.org\/10.1038\/s41424-018-0007-6.","journal-title":"Clin Transl Gastroenterol."},{"key":"7056_CR32","unstructured":"2018 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; February 28, 2018"},{"key":"7056_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12879-018-3192-8","volume":"18","author":"L Chen","year":"2018","unstructured":"Chen L, Bao D, Gu Y et al. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect Dis. 2018;18:295. https:\/\/doi.org\/10.1186\/s12879-018-3192-8.","journal-title":"BMC Infect Dis."},{"key":"7056_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hep.510310129","volume":"31","author":"WM Wong","year":"2000","unstructured":"Wong WM, Wu PC, Yuen MF et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology. 2000;31:201\u2013206.","journal-title":"Hepatology."},{"key":"7056_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00408-013-9535-8","volume":"192","author":"YM Liu","year":"2014","unstructured":"Liu YM, Cheng YJ, Li YL, Liu CE, Hsu WH. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. Lung 2014;192:205\u2013210.","journal-title":"Lung"},{"key":"7056_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jcma.2015.12.006","volume":"79","author":"NT Wang","year":"2016","unstructured":"Wang NT, Huang YS, Lin MH, Huang B, Perng CL, Lin HC. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: systematic review and meta-analysis. J Chin Med Assoc. 2016;79:368\u2013374.","journal-title":"J Chin Med Assoc."},{"key":"7056_CR37","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/jac\/dkz068","volume":"74","author":"M Cerrone","year":"2019","unstructured":"Cerrone M, Alfarisi O, Neary M et al. Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide. J Antimicrob Chemother. 2019;74:1670\u20131678.","journal-title":"J Antimicrob Chemother."},{"key":"7056_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/COH.0000000000000376","volume":"12","author":"G Maartens","year":"2017","unstructured":"Maartens G, Boffito M, Flexner CW. Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settings. Curr Opin HIV AIDS 2017;12:355\u2013358.","journal-title":"Curr Opin HIV AIDS"},{"key":"7056_CR39","unstructured":"Custodio JM, West SK, Lutz J, et al. Twice Daily Administration of Tenofovir Alafenamide in Combination with Rifampin: Potential for Tenofovir Alafenamide Use in HIV-TB Coinfection. In: Program and abstracts of the 16th European AIDS Conference; October 25\u201327, 2017; Milan, Italy. [Abstract PS13\/4 2017]."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07056-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T16:11:07Z","timestamp":1654359067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,30]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7056"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07056-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,30]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jennie Chen: None, Ashley Hubbard: None, Laurie Bagley: None, Rita Shiau: None, Robert J. Wong: Advisory board, consultant, and research grants \u2013 Gilead Sciences. Amit S. Chitnis: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}